Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2Plasma cell 1

Conditions

Prostatic Neoplasms 1Plasmacytoma 1Multiple Myeloma 1

Interventions

Specimen Handling 4Zoledronic Acid 3Vorinostat 3Azacitidine 3venetoclax 2trametinib 2ruxolitinib 2pertuzumab 2palbociclib 2dabrafenib 2copanlisib 2abiraterone 2Sunitinib 2Sorafenib 2Oxaliplatin 2Nivolumab 2Magnetic Resonance Spectroscopy 2Leucovorin 2Immunoglobulin G 2HhAntag691 2Fluorouracil 2Doxorubicin 2Disulfides 2Dasatinib 2Clodronic Acid 2Bevacizumab 2Afatinib 2Ado-Trastuzumab Emtansine 22C4 antibody 2ulixertinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Sodium Selenite × Plasma cell × Clear all
NCT02184533 2024-05-28

Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer

Stanford University

Phase 1 Completed
15 enrolled
GenitourinaryPlasma cell

Multiple Myeloma, Plasmacytoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡